Clinical Trials Logo

Clinical Trial Summary

A more rapid test for bacteriuria is desired. This will exclude the patients not having bacteriuria, which will contribute to a more rapid and accurate diagnosis of infectious diseases. The aim of the study is to investigate the diagnostic accuracy of point-of-care urine flow cytometry on diagnosing and excluding bacteriuria


Clinical Trial Description

A prerequisite for the appropriate use of antibiotics is timely access to accurate diagnostic tests, since treatment of acute infections should be initiated within a few hours to avoid serious complications such as bacteremia, sepsis, organ failure, septic shock and death. The diagnosis of urinary tract infections including acute pyelonephritis (APN) is difficult due to often weak and non-specific symptoms and high incidence of asymptomatic bacteruria in especially elderly patients. The diagnosis is verified by significant bacteriuria in urine culture. Unfortunately, the time from urine sample to result from urine cultures is more than 24 hours days. Urine test strips are unreliable with low specificity and low predictive values. Therefore, a point-of-care (POC) test is desired, which can provide rapid results and quickly identify a bacteriuria. One such tool may be urine flow cytometry (UFC), which has shown promising diagnostic value for the exclusion of bacteriuria with a high negative predictive value. However, better documentation for its use as an ED diagnostic screening method is needed. The aim of the study is to investigate the diagnostic accuracy of POC-UFC on diagnosing and excluding bacteriuria? Our hypothesis is that by excluding patients not having bacteriuria, it will contribute to a more rapid and accurate diagnosis ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04686292
Study type Observational
Source University of Southern Denmark
Contact
Status Completed
Phase
Start date March 1, 2021
Completion date June 1, 2022

See also
  Status Clinical Trial Phase
Completed NCT04690569 - Establish MeMed BV™ Performance for Differentiating Bacterial From Viral Infection in Suspected Acute Infection Patients (APOLLO STUDY)
Completed NCT04182906 - Pediatric ACEs Screening and Resiliency Study N/A
Completed NCT05439551 - Evaluating the Analytical Equivalency of Serum and Whole Blood Samples Run on the MeMed Key® Platform (Perseverance Study)
Completed NCT03494790 - Markers of Inflammation and Metabolism in the ER
Completed NCT05293977 - Short-Term Use of Antibiotics and Adherence Level N/A
Recruiting NCT05758246 - Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial Phase 2
Completed NCT06040684 - Development of Antibodies Against Transplant Kidney After Infection